TAK-242

DRUG2 trials

Sponsors

Akaza Bioscience Ltd, Yaqrit Ltd

Conditions

Acute-On-Chronic Liver FailureAlcoholic HepatitisLiver Cirrhosis, Alcoholic

Phase 2

TAK-242 in Patients With Acute Alcoholic Hepatitis

TerminatedNCT04620148

Akaza Bioscience LtdAcute-On-Chronic Liver Failure

Start: 2020-11-12End: 2022-03-31Updated: 2026-10-14

A-TANGO Phase 2 Study

RecruitingNCT06890039

Yaqrit LtdAcute-On-Chronic Liver Failure, Alcoholic Hepatitis, Liver Cirrhosis, Alcoholic

Start: 2026-06-29End: 2028-12-31Target: 78Updated: 2026-09-21